Fidelity Disruptors ETF (FDIF)

The Fidelity Disruptors ETF (FDIF) invests in companies disrupting their industries regardless of sector. While most equity funds organise by industry category, FDIF cuts across sectors to find the disruptors wherever they emerge — from technology firms reimagining software to healthcare innovators developing new treatments to industrial companies automating manufacturing.

How disruption is the investment lens

FDIF’s philosophy is that disruption is not confined to technology sectors. A biotech firm using gene therapy cures diseases that traditional medicine could only manage, disrupting the entire healthcare model. An industrial company using robotics and software automation transforms manufacturing. An energy company developing battery technology disrupts oil’s dominance in transportation. A e-commerce logistics operator disrupts traditional retail distribution. By looking across the entire market for companies gaining competitive advantage through innovation or business-model reimagining, FDIF captures disruption wherever it emerges.

Fidelity’s managers define disruption as companies gaining market share by offering superior products or services that legacy competitors cannot easily replicate, reimagining business models fundamentally, or leveraging technology to undercut entrenched players. This theme works across any industry, making FDIF a thematic fund organised by investment principle rather than sector classification.

Technology disruption: the largest segment

Technology remains the most visible source of disruption. Software companies replacing entire workflows, semiconductor firms enabling new capabilities, cloud-infrastructure providers enabling new business models, and artificial-intelligence companies automating complex tasks all represent genuine disruption. FDIF’s holdings in technology typically include established leaders in software and semiconductors alongside newer platforms where software is eating categories previously dominated by traditional hardware companies. The concentration in technology reflects both the prevalence of technology-driven disruption and the visibility of tech disruption to investors and analysts.

Healthcare and life sciences innovation

Healthcare is undergoing its own disruption through biotechnology and medical innovation. Gene therapy, monoclonal antibodies, advanced diagnostics, and artificial-intelligence-driven drug discovery are reshaping how diseases are treated. Medical-device companies innovating around minimally invasive procedures, telemedicine platforms, and precision-medicine approaches are displacing traditional hospital-centric care models. FDIF holds healthcare disruptors — companies developing novel treatments, deploying new diagnostic methods, or reimagining healthcare delivery — alongside software companies and semiconductor vendors.

Industrial and energy transformation

Traditional industrials are being disrupted by technology and new materials. Robotics and software automation are reshaping manufacturing. Advanced materials and chemistry are creating superior alternatives to legacy products. Energy companies developing battery technology, hydrogen fuel systems, and other alternatives to fossil fuels are disrupting the energy sector. FDIF’s industrial holdings capture companies at the forefront of these transitions, not traditional industrial companies making incremental improvements.

Consumer and financial services disruption

Consumer-facing disruption includes e-commerce platforms replacing retail, digital payment systems replacing traditional banking, and subscription models replacing transaction-based consumption. Financial-technology companies offering cheaper, faster services than legacy institutions are gaining share. FDIF holds companies disrupting these sectors through superior technology or business models.

Active selection and manager judgment

Because FDIF is actively managed, Fidelity’s investment team must distinguish genuine disruption from incremental improvement and marketing hype. This requires deep sector knowledge and forward-looking judgment. A software company adding features is not disruption; a company making an entire category obsolete is. A medical device that is slightly better than existing options is not disruption; a therapy that cures a previously incurable disease is. This judgment is subjective and difficult. If managers misidentify which innovations will stick and which will fade, the fund lags.

The portfolio’s composition reflects these judgments. Because the fund is not sector-balanced, holdings concentrate in areas where managers see the strongest disruption. If they see stronger disruption emerging in biotech than in software one year, the portfolio tilts that way. This flexibility is an advantage — the fund is not forced to equal-weight sectors — but it creates concentration risk if managers’ disruption thesis proves wrong.

Risks of timing and valuation

Disruption timing is difficult to forecast. Many companies appear genuinely disruptive based on a few years of fast growth but slow sharply once they hit market ceilings or face competitive response. High-growth disruption stories often trade at high valuations because investors are paying for future earnings. When sentiment shifts or interest rates rise, these stocks can sell off sharply. FDIF’s returns are sensitive to both the broader economic cycle and investor sentiment toward growth and innovation.

The fund’s concentration in thematic bets also creates risk. An actively managed portfolio overweights highest-conviction ideas; if those big bets are wrong, the fund underperforms dramatically. If managers overweight artificial-intelligence companies and AI adoption stalls, or if they overweight biotech and new therapies face regulatory rejection, the portfolio suffers.

How to research FDIF

FDIF suits investors who believe disruption is accelerating across industries and who can accept the risk that managers’ disruption thesis may miss. It works best as a satellite or thematic holding in a diversified portfolio, not as a core equity position.

Read FDIF’s prospectus and fact sheet from Fidelity, paying attention to the fund’s strategy and manager experience. Review top holdings and sector composition to see where managers are placing disruption bets. Compare FDIF’s returns to broad market indices and to other growth or innovation-focused funds to evaluate whether the disruption focus adds value. Track holdings changes and turnover, which reveal how actively managers are repositioning as they refine their disruption thesis.